Kiniksa Pharmaceuticals International (KNSA) Cash Flow: Operating & Free Cash Flow

Kiniksa Pharmaceuticals International (KNSA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Kiniksa Pharmaceuticals International generated $137.99M of operating cash flow and spent $1.57M on capital expenditures. That left free cash flow of $136.42M, up 436.8% from $25.41M a year earlier, or 20.1% of revenue. It repurchased $7.73M of its own shares.

Kiniksa Pharmaceuticals International Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Kiniksa Pharmaceuticals International, plc (KNSA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	59.01	-43.19	14.08	183.36	-157.92	-161.38	-161.87	-103.23	-64.87
Depreciation & Amortization	1.55	1.70	2.34	2.40	2.36	2.41	2.07	0.29	0.03
Deferred Income Tax	13.00	8.13	-33.79	-185.50	0.01	4.36	-3.16	-0.98	-0.20
Stock Based Compensation	37.00	30.69	27.15	25.12	25.17	20.88	15.08	5.70	0.90
Change in Working Capital	24.79	24.81	1.35	-22.58	0.69	-4.32	-17.03	18.33	13.93
Change in Accounts Receivable	-2.71	26.13	-20.46	-8.68	-3.91	0.00	0.00	0.00	0.00
Change in Inventory	-28.53	4.76	-9.52	-17.92	-3.68	0.00	0.00	0.00	0.00
Change in Accounts Payable	0.14	-6.31	0.35	6.03	1.37	-4.97	-4.71	8.82	1.01
Change in Other Working Capital	-25.04	-27.51	-26.37	-10.30	2.63	0.65	-12.32	9.51	12.92
Other Operating Activities	15.63	11.69	2.17	-182.50	2.63	5.76	6.53	-1.12	-0.05
Net Cash from Operating Activities	137.99	25.69	13.30	5.81	-126.30	-136.53	-158.37	-81.01	-50.22
Investing Activities
Capital Expenditures	-1.57	-0.28	-0.13	-0.11	-20.42	-0.28	-3.20	-5.29	-0.07
Acquisitions	0.00	0.03	0.00	0.00	0.00	23.16	-52.42	0.00	0.00
Purchases of Investments	-386.92	-202.01	-204.93	-135.86	-157.25	-23.16	-488.77	-402.01	0.00
Sales/Maturities of Investments	199.49	239.94	175.51	127.80	306.30	407.05	541.19	168.10	0.00
Other Investing Activities	0.03	0.00	0.00	0.09	-20.00	-23.16	52.42	-233.91	0.00
Net Cash from Investing Activities	-188.99	37.67	-29.56	-8.08	128.64	-23.44	49.21	-239.20	-0.07
Financing Activities
Common Stock Issued	40.75	17.25	3.70	3.42	5.89	228.22	83.11	159.19	39.87
Common Stock Repurchased	-7.73	-4.98	-2.21	-0.90	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	20.00	17.25	3.70	-0.90	5.89	-1.14	1.00	187.54	39.87
Net Cash from Financing Activities	33.02	12.27	1.50	2.52	5.89	227.09	84.11	346.74	39.87
Summary
Net Change in Cash	-17.99	75.63	-14.76	0.25	8.22	67.11	-25.05	26.53	-10.42
Cash at Beginning of Period	183.58	107.95	122.72	122.47	114.25	47.14	72.19	45.66	56.08
Cash at End of Period	165.60	183.58	107.95	122.72	122.47	114.25	47.14	72.19	45.66
Free Cash Flow	136.42	25.41	13.17	5.70	-146.71	-136.82	-161.57	-86.30	-50.29
Supplemental Disclosures
Income Taxes Paid	-	2.00	5.61	10.69	1.28	0.48	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Kiniksa Pharmaceuticals International Cash Flow

What is Kiniksa Pharmaceuticals International's free cash flow?

Kiniksa Pharmaceuticals International generated free cash flow of $136.42M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $137.99M minus $1.57M of capital expenditures. That was up 436.8% from $25.41M a year earlier. Free cash flow equaled 20.1% of revenue.

How much does Kiniksa Pharmaceuticals International spend on capital expenditures?

Kiniksa Pharmaceuticals International spent $1.57M on capital expenditures in fiscal 2025, compared with $277.00K a year earlier. That equals 1.1% of operating cash flow.

Does Kiniksa Pharmaceuticals International pay dividends or buy back shares?

Yes. In fiscal 2025 Kiniksa Pharmaceuticals International returned $7.73M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition